Home Topics OMICs RNAi Technology RNAi Technology March 22, 2007 – GEN’s Editor-in-Chief John Sterling interviews Richard Jorgensen, Ph.D., from the University of Arizona /wp-content/uploads/2018/09/gc87_3_22_2007.mp3 PodcastsResourcesCellular, Molecular and Developmental BiologyMolecular biologyNucleic acidsRNARNA biologyRNA interference Also of Interest Bruker to Acquire NanoString with $392.6M Winning Bid Universal Vaccine Strategy Boosts Body's RNAi Response to Viruses SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR New Insights Could Boost Immunotherapy for Rare Eye Cancer Long-Lived RNA in Nerve Cells Can Last a Lifetime Novel RNA Therapeutic Modalities Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT's Hot News Decoding Genomic Diversity with deCODE Genetics CEO Kári Stefánsson on "Close to the Edge" Related Content Bruker to Acquire NanoString with $392.6M Winning Bid Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR New Insights Could Boost Immunotherapy for Rare Eye Cancer